Bio-Rad Reports Second-Quarter 2019 Financial Results

Go back to Bio-Rad Reports Second-Quarter 2019 Financial Results

Bio-Rad Labs (BIO) Tops Q2 EPS by 24c

August 1, 2019 4:40 PM EDT

Bio-Rad Labs (NYSE: BIO) reported Q2 EPS of $1.57, $0.24 better than the analyst estimate of $1.33. Revenue for the quarter came in at $572.6 million versus the consensus estimate of $566.19 million.

For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.

... More